Tel Aviv University utilized updated FDA-recommended outcome measures in its research.

The entities involved

• FDA →
  • The FDA reviewed risks and loosened the label on testosterone replacement therapy (TRT) following an attempt by the Trump administration to reverse its decline.23:10
  • PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.21:51
• Tel Aviv University →

  university in Tel Aviv, Israel

  • Researchers at Tel Aviv University conducted a study on Israeli migration.Wed 18:18
  • A university study reported in Israel concerning Nespresso-compatible capsules sold by the supermarket chain Shufersal.Mon 12:18

Related events

• A company is seeking definitive data for a pre-NDA meeting with the FDA in Raleigh.Oct 6
• FDA provided guidance for HCW Biologics' IND application.Oct 9
• A company submitted study data supporting a PMA submission to the FDA.Jun 8
• Research advances have led to the approval of new therapies by the FDA.Oct 15
• FDA communicated eligibility for accelerated approval for ProKidney Corp., which plans to present study results at ASN.Jun 8